MOOGENE MEDI

moogene-medi-logo

Moogene Medi is a biotechnology company that specializes in gene therapy and development of drug delivery systems using nano-bio technology.

#Website #More

MOOGENE MEDI

Industry:
Biopharma Biotechnology Nanotechnology Product Research

Founded:
2016-06-22

Address:
Hanam, Kyonggi-do, South Korea

Country:
South Korea

Website Url:
http://www.moogene.com

Total Employee:
1+

Status:
Active

Contact:
+82-031-628-6886

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx PHP PHP 7 Korea Telecom LINE WORKS


Official Site Inspections

http://www.moogene.com

  • Host name: 203.245.24.20
  • IP address: 203.245.24.20
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Moogene Medi"

MOOGENE MEDI - ๋ฌด์ง„๋ฉ”๋””

We develop novel therapeutics by developing optimized LNPs based on each drugโ€™s characteristics.See details»

Moogene Medi - Crunchbase Company Profile & Funding

Moogene Medi is a biotechnology company that specializes in gene therapy and development of drug delivery systems using nano-bio technology. A system for effectively loading hydrophobic โ€ฆSee details»

Moogene Medi Co., Ltd. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Moogene Medi Co., Ltd. of Hanam, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»

Moogene Medi Company Description - Stock Analysis

Nov 13, 2024ย ยท Moogene Medi Co., Ltd. develops gene therapies based on its proprietary gene-editing platform technology. The companyโ€™s product portfolio comprises MG-001, which is in โ€ฆSee details»

Moogene - Overview, News & Similar companies | ZoomInfo.com

View Moogene (www.moogene.com) location in South Korea , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

322970 | Moogene Medi Co. Ltd. Profile | MarketWatch

It develops nanomaterials and nanotechnology for gene therapy. The company was founded on June 22, 2016 and is headquartered in Hanam-si, South Korea. Moogene Medi Co. Ltd. โ€ฆSee details»

Company Moogene Medi Co., Ltd. - MarketScreener.com

Oct 10, 2024ย ยท Moogene medi Co Ltd is a Korea-based company mainly engaged in the research and development of biological and chemical agents capable of treating incurable diseases. โ€ฆSee details»

Moogene Medi Co., Ltd. - EverybodyWiki Bios & Wiki

Moogene Medi Co., Ltd. (Moogene) is a leading nano-biomaterials company headquartered in South Korea that develops gene therapies based on its proprietary nano-delivery technology. โ€ฆSee details»

Moogene Medi - Funding, Financials, Valuation & Investors

Moogene Medi is a biotechnology company that specializes in gene therapy and development of drug delivery systems using nano-bio technology.See details»

Organization: Moogene Medi - Cbonds.com

Moogene Medi Co. Ltd. operates biotechnology development businesses. The Company develops nanotechnology, genetic technologies, and other technologies. Moogene Medi conducts โ€ฆSee details»

Emmanuel Hui - CoFounder at Moogene - ๆธฏๅ‰ตไบบ Hong Kong โ€ฆ

Emmanuel A. HUI is a co-founder of Moogene, a gene therapy company listed on the Korean stock exchange (322970.KS). After his first company, HUI then founded Angene - a cancer โ€ฆSee details»

322970 Stock Price Quote | Morningstar

Nov 15, 2024ย ยท See the latest Moogene Medi Co Ltd Ordinary Shares stock price (322970:XKRX), related news, valuation, dividends and more to help you make your investing decisions.See details»

Moogene Medi: HUTERA Sonicated Topical Dutasteride ... - Follicle โ€ฆ

May 26, 2022ย ยท Moogene Medi of Korea shares an update on their topical anti-DHT therapies utilizing microbubble delivery and ultrasound technology with limited systemic exposure. In โ€ฆSee details»

Moogene Medi Co Ltd Stock Price Today - Investing.com

View today's Moogene Medi Co Ltd stock price and latest 322970 news and analysis. Create real-time notifications to follow any changes in the live stock price.See details»

The booming business of hair loss: Trends in Biotechnology - Cell โ€ฆ

Jan 18, 2023ย ยท Moogene Medi is the first company to use the CRISPR/Cas9 gene-editing technology to target the SRD5A2 gene that codes for steroid 5-alpha-reductase 2, an enzyme โ€ฆSee details»

The booming business of hair loss - ScienceDirect

Jun 1, 2023ย ยท Moogene Medi is the first company to use the CRISPR/Cas9 gene-editing technology to target the SRD5A2 gene that codes for steroid 5-alpha-reductase 2, an enzyme โ€ฆSee details»

Pangen, Moogene Medi seek patent on LNP technology

Aug 8, 2022ย ยท Pangen Biotech announced Monday that it signed a joint development agreement with Moogene Medi to develop a protein treatment using lipid nanoparticles (LNPs). The two โ€ฆSee details»

CRISPR/Cas9 Therapy For Androgenic Alopecia: Moogene Medi

Nov 29, 2020ย ยท Moogene Medi of South Korea is the first company to formally introduce a CRISPR-based gene editing hair loss therapy to the world. Moogene has developed a โ€ฆSee details»

Trends in Biotechnology OPEN ACCESS - Cell Press

With the prospect of a hair loss cure and its business, biotechnology companies have begun to develop more effective treatments for AGA. Here, we benchmark those biotechs, high-lighting โ€ฆSee details»

Genomic organization - Wikipedia

Genomic organization refers to the linear order of DNA elements and their division into chromosomes. "Genome organization" can also refer to the 3D structure of chromosomes and โ€ฆSee details»